Showing 3621-3630 of 4063 results for "".
- EnChroma Names Vision Industry Veteran Erik Ritchie as CEOhttps://modernod.com/news/enchroma-names-vision-industry-veteran-erik-ritchie-as-ceo/2478743/EnChroma, creators of EnChroma eyewear for color blindness, named Erik Ritchie as its CEO. Mr. Ritchie brings 25 years of experience in the optical industry and other fields. Most recently, he served as Chief Commercial Officer for Zenni Optical, the largest online provider of prescription eyewea
- CorNeat Vision’s First Patient Regains Sight Following Artificial Cornea Implantation at Rabin Medical Centerhttps://modernod.com/news/corneat-visions-first-patient-regains-sight-following-artificial-cornea-implantation-at-rabin-medical-center/2478741/The CorNeat KPro, an artificial cornea that integrates with the eye wall with no reliance on donor tissue, was successfully implanted in a human. The surgery was performed on a bilaterally blind, 78-year-old male at Rabin Medical Center, Israel, by Professor
- Graybug Vision Completes Treatment Phase of ALTISSIMO Trial in Wet AMD with 12-Month Topline Datahttps://modernod.com/news/graybug-vision-completes-treatment-phase-of-altissimo-trial-in-wet-amd-with-12-month-topline-data/2478738/Graybug Vision announced the last patient visit in its GB-102 phase 2b ALTISSIMO core trial (the 12-month treatment phase) in wet age-related macular degeneration (AMD). ALTISSIMO 12-month topline data are expected to be announced in the second quarter of 2021, with full results to b
- Nicox’s Licensee Bausch + Lomb Launches Vyzulta in Mexicohttps://modernod.com/news/nicoxs-licensee-bausch-lomb-launches-vyzulta-in-mexico/2478720/Nicox announced that an affiliate of its licensee, Bausch + Lomb, has launched Vyzulta (latanoprostene bunod ophthalmic solution), 0.024% in Mexico. Approval was obtained in Mexico in January 2020. Vyzulta is indicated for the reduction of IOP in patients with open-angle glaucoma or ocular
- Study: Hospitals At or Near Full COVID-19 ICU Capacity Increase by 90% Over Past Few Monthshttps://modernod.com/news/study-hospitals-at-or-near-full-covid-19-icu-capacity-increase-by-90-over-past-few-months/2478722/A new study found a 90% increase in hospitals reaching intensive care unit (ICU) capacity from July through December, with rural hospitals facing the biggest capacity issues, according to a FierceHealthcare
- CureVac and the University Medical Center Mainz Start Phase 3 Clinical Trial for COVID-19 Vaccine Candidatehttps://modernod.com/news/curevac-and-the-university-medical-center-mainz-start-phase-3-clinical-trial-for-covid-19-vaccine-candidate-cvncov-in-healthcare-workers/2478683/CureVac NV announced that the first participant in a clinical phase 3 study with its COVID-19 vaccine, CVnCoV, in healthcare workers at the University Medical Center Mainz will be vaccinated on December 22, 2020. The study aims to evaluate the safety and immunogenicity of CVnCoV administered as a
- Kubota Vision Provides Update on Kubota Glasses—Wearable Device for Myopia Controlhttps://modernod.com/news/kubota-vision-provides-update-on-kubota-glasses-wearable-device-for-myopia-control/2478680/Kubota Vision announced that the company achieved a milestone by completing a first spectacle-style wearable prototype based on Kubota Glasses technology. Kubota Vision conducted a clinical study in early 2020 with an electronic tabletop optical projection device that embodied Kubota Glass
- Influx of New Contact Lens Patients Calls for Simplified Wear-and-Care Educationhttps://modernod.com/news/influx-of-new-contact-lens-patients-calls-for-simplified-wear-and-care-education/2478671/Within days of mask guidelines being implemented earlier this year, the reports of fogging started streaming in from glasses and sunglasses wearers. Social feeds were soon packed with photos of the annoying condensation and news reports began offering tips on how to avoid condensation. In 2020, t
- Most Doses of Lilly, Regeneron’s COVID-19 Antibody Treatments Are Going Unusedhttps://modernod.com/news/most-doses-of-lilly-regenerons-covid-19-antibody-treatments-are-going-unused/2478665/Moncef Slaoui, chief scientific advisor to the US government’s Operation Warp Speed program, estimates that only 5% to 20% of the roughly 65,000 doses of COVID-19 antibody treatments shipped to states around the country every week end up going to patients. He suggested this was disappointin
- US Government to Buy 100 Million More Doses of Moderna’s COVID-19 Vaccinehttps://modernod.com/news/us-government-to-buy-100-million-more-doses-of-modernas-covid-19-vaccine/2478657/Moderna announced that the US government has exercised its option to purchase an additional 100 million doses of the drugmaker’s COVID-19 vaccine candidate mRNA-1273, bringing its confirmed order commitment to 200 million doses in the US. CEO Stéphane Bancel remarked that “we c